RBF Jumps 4% after Obtaining an Additional License for Hemp Cultivation
RBF rose ฿0.90/share or 4.15% to ฿22.60/share as of 16:12 local time in Thailand, with a trading value of 392 million baht
RBF rose ฿0.90/share or 4.15% to ฿22.60/share as of 16:12 local time in Thailand, with a trading value of 392 million baht
13 ก.ค. 2564

The share price of R&amp;B Food Supply Public Company Limited (RBF) rose ฿0.90/share or 4.15% to ฿22.60/share as of 16:12 local time in Thailand, with a trading value of 392 million baht, following the announcement that the company and its subsidiary has been additional approved of Narcotics Substance Category 5, Hemp Only.
The Food and Drug Authority has issued the Produce License of Narcotics Substance Category 5, Hemp Only, License No. ChorMor 9/2564(Por), ChorMor 10/2564(Por), ChorMor 11/2564(Por) to the company for industrial and commercial benefits. 
Obtaining those licenses, the company is able to cultivate hemp by order of the customers. The products of cultivation shall be extracted for CBD-THC and hemp seed oil at the plant, and procession by other means for distributing to producer of food, beverage, cosmetics, herbs, supplementary foods, and other products under the regulation of the Food and Drug Authorization to distribute both domestically and internationally, expected that shall be income in Q4 of 2021.
Additionally, the Food and Drug Authority has issued the Produce License of Extract Hemp Seed Oil by endorsed for food category on Produce License No. 50-2-06745 which is given  to the company’s subsidiary, Premium Foods  Company Limited to add specific controlled foods namely: hemp seeds, hemp seed oil, hemp seed protein and food products included with hemp seeds, hemp seed oil, hemp seed protein (only hemp seed oil) that has been registered. 
Whereby obtaining the aforesaid license, the subsidiary is able to extract hemp seed oil, the  products of extraction shall be used for foods, beverages, cosmetics, herbs, supplementary  foods, and other products under the regulations of Food and Drug Authority to distribute  both domestically and internationally, expected that shall be income in Q4 of 2021.